Intravenous antiplatelet therapy – for when the going gets tough
In the second instalment of our antiplatelet therapy series, we take a look at intravenous (IV) antiplatelet therapy and how it came to be used. In a previous blog1, we provided a brief overview of the 50-year evolution of oral anti-platelet therapy, which began with the findings of the first randomised, controlled trial of aspirin […]
